Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 8, 2003, Pages 3621-3625

  Cagnacci, Angelo ^a   Paoletti, A M ^b   Renzi, A ^a   Orru M ^b   Pilloni, M ^b   Melis, G B ^b   Volpe, A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; DIANE; ETHINYLESTRADIOL; GLUCOSE; INSULIN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; GLUCOSE METABOLISM; HORMONAL CONTRACEPTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; ORAL CONTRACEPTION; ORAL GLUCOSE TOLERANCE TEST; OVARY DISEASE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BODY WEIGHT; C-PEPTIDE; CONTRACEPTIVES, ORAL, HORMONAL; CYPROTERONE ACETATE; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HORMONES; HUMANS; INSULIN; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME;

FALLOPIA;

EID: 0041883275     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030328     Document Type: Article

References (37)

1. Carmina E, Lobo RA 1999 Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathies associated with significant morbidity in women. J Clin Endocrinol Metab 84:1897-1899
2. Dunaif A 1994 Polycystic ovary syndrome. Curr Ther Endocrinol Metab 5:222-229
3. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
4. Dunaif A, Finegood D 1996 β-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:942-947
5. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
6. Legro RS 2001 Polycystic ovary syndrome: The new millenium. Mol Cell Endocrinol 184:87-93
7. Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ 2001 Relative risk of conversion from normoglycemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 16:1995-1998
8. Cibula D., Cifkova R., Fanta M, Poledne R, Zivny J, Skibova J 2000 Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycistic ovary syndrome. Hum Reprod 15:785-789
9. Nestler JE 1997 Insulin Regulation of human ovarian androgens [Review]. Hum Reprod 12(Suppl 1):53-62
10. Paradisi G, Steimberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD 2001 Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 13:1410-1415
11. Kelly CJG, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JMC 2002 Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87:742-746
12. Matter KJ, Kwan F, Corenblum B 2000 Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 73:150-156
13. Kasdorf G, Kalkhoff RK 1988 Prospective studies of insulin sensitivity in normal women receiving oral contraceptive agents. J Clin Endocrinol Metab 66:846-852
14. Skouby SO, Andersen O, Saurberey N, Kuhl C 1987 Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes. J ClIn Endocrinol Metab 64:519-523
15. Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V 1992 Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 74:64-70
16. Nader S, Riad-Gabriel MG, Saad MF 1997 The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women. J Clin Endocrinol Metab 82:3074-3077
17. Pasquali R, Fabbri R, Venturoli S, Paradisi S, Antenucci D, Melchionda N 1986 Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries. Am J Obstet Gynecol 154:139-114
18. Dahlgren E, Landin K, Krotkiewski M, Holm G, Janson PO 1998 Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 13:2706-2711
19. Armstrong VL, Wiggan MI, Ennis CN, Sheridan B, Traub AI, Atkinson AB, Bell PM 2001 Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate. Q J Med 94:31-37
20. Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Martikainen K, Tapanainen JS 2000 Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 85:3161-3168
21. Cibula D, Fanta M, Hill M, Sindelka G, Skrha J, Zivny J 2002 Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. Hum Reprod 17:76-82
22. Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Martikainen K, Tapanainen JS 2003 Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 88:148-156
23. Korytkowski M, Mokan M, Horwitz M, Berga S 1995 Metabolic effects of oral contraceptives in women with polycystic ovary syndrome. J Clin Endocrinol Metab 80:3327-3334
24. Paoletti AM, Cagnacci A, Soldani R, Orrù M, Ajossa S, Pittorra G, Mulas P, Melis GB 1995 Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome. Fertil Steril 64:1094-1098
25. Welch S, Gebhart SSP, Bergman RN, Phillips LS 1990 Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetics subjects. J Clin Endocrinol Metab 71:1508-1518
26. Cagnacci A, Arangino S, Renzi A, Cagnacci P, Volpe A 2001 Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting. Eur J Endocrinol 145:281-287
27. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB 1992 Effect of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74:1396-1400
28. Cagnacci A, Tuveri F, Cirillo R, Setteneri AM, Melis GB, Volpe A 1998 The effect of 17β-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration. Maturitas 28:163-167
29. American Diabetes Association 1998 Consensus development conference on insulin resistance. Diabetes Care 21:310-314
30. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SSC 1992 Cellular mechanisms of insulin resistance in polycystic ovary sindrome. J Clin Endocrinol Metab 75:577-583
31. Falcone T, Little AB, Morris D 1992 Impaired glucose effectiveness in patients with polycystic ovary syndrome. Hum Reprod 7:922-925
32. Cagnacci A, Paoletti AM, Arangino S, Melis GB, Volpe A 1999 Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism. Hum Reprod 14:893-897
33. Bonora E, Zavaroni I, Coscelli C, Butturini U 1983 Decreased hepatic insulin extraction in subject with mild glucose intolerance Metabolism 32:438-446
34. Elter K, Imir G, Durmusoglu F 2002 Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study. Hum Reprod 17:1729-1737
35. Godsland IP, Stevenson JC 1995 Insulin resistance: syndrome or tendency? Lancet 346:100-103
36. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, Lobo RA 1993 A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 60:664-667
37. Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM 1999 The natural history of the metabolic syndrome in young women with the polycystic ovary sindrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf) 50:517-527